1EIKELBOOM J W,WEITZ J I. New anticoagulants[J].Circulation,2010,121(13):1523-1532.
2DOUKETIS J,TOSETTO A,MARCUCCI M,et al. Risk ofrecurrence after venous thromboembolism in men andwomen:patient level meta-analysis[J]. BMJ,2011,342:d813.
3GALIOTO N J,DANLEY D L,VAN MAANEN R J,et al.Recurrent venous thromboembolism [J]. Am FamPhysician,2011,83(3):293-300.
4AGENO W,BECATTINI C,BRIGHTON T,et al. Cardiovas-cular risk factors and venous thromboembolism: a meta-analysis[J]. Circulation,2008,117(1):93-102.
5EICHINGER S,HRON G,BIALONCZYK C,et al. Over-weight, obesity, and the risk of recurrent venousthromboembolism[J]. Arch Intern Med,2008,168(15):1678-1683.
6TRIPODI A. D-dimer testing in laboratory practice[J]. ClinChem,2011,57(9):1256-1262.
7WEITZ J I,GROSS P L. New oral anticoagulants:which oneshould my patient use[J]. Hematol Am Soc Hematol EducProgram,2012:536-540.
8KEARON C,KAHN S R,AGNELLI G,et al. Antithrombotictherapy for venous thromboembolic disease: americancollege of chest physicians evidence-based clinical practiceguidelines [J]. Chest,2008,133(6 Suppl):454-545.
9GARCIA D,BARRETT Y C,RAMACCIOTTI E,et al. La-boratory assessment of the anticoagulant effects of the nextgeneration of oral anticoagulants[J]. J Thromb Haemost,2013,11(2):245-252.
10RUIZ-GIMENEZ N,SUAREZ C,GONZALEZ R,et al. Pre-dictive variables for major bleeding events in patientspresenting with documented acute venousthromboembolism. Findings from the RIETE Registry[J].Thromb Haemost,2008,100(1):26-31.
